Business Of Biotech cover image

The Innovation Reduction Act with Allan Shaw

Business Of Biotech

00:00

The Alanchaw Approach to Healthcare in America

Alan Alanchaw: How do you facilitate optimal cost-effective patient access to innovative medicines while providing the necessary financial rewards and incentives to keep the prolific scientific engines running? The way we administer healthcare is regressive because the patients are the ones that are administrating this and paying for it, he says. Until we fix that, right, there's no focus on outcome, everything’s about focusing on costs, Alan writes. "No good deed goes unpunished," Dr. Alanchaw adds.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app